Inhibitory effects of astragaloside IV on ovalbumin-induced chronic experimental asthma

Canadian Journal of Physiology and Pharmacology

Volumn 86, Issue 7, 2008, Pages 449-457

  Du, Qiang ^a   Chen, Zhen ^a   Zhou, Lin Fu ^a   Zhang, Qian ^a   Huang, Mao ^a   Yin, Kai Sheng ^a  

^a NANJING MEDICAL UNIVERSITY   (China)

Author keywords

Airway remodeling; Astragaloside IV; Astragalus membranaceus; Chronic asthma

Indexed keywords

ASTRAGALOSIDE IV; IMMUNOGLOBULIN E; INTERLEUKIN 13; INTERLEUKIN 4; OVALBUMIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIINFLAMMATORY ACTIVITY; ARTICLE; ASTHMA; BRONCHODILATING ACTIVITY; BRONCHUS HYPERREACTIVITY; CONTROLLED STUDY; FEMALE; HISTOPATHOLOGY; INFLAMMATION; LUNG LAVAGE; MOUSE; NONHUMAN; PRIORITY JOURNAL;

ACTINS; ALLERGENS; ANIMALS; ANTI-ASTHMATIC AGENTS; ASTHMA; BRONCHI; BRONCHOALVEOLAR LAVAGE FLUID; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; CHRONIC DISEASE; COLLAGEN; CYTOKINES; FEMALE; FIBROSIS; HYDROXYPROLINE; MICE; MICE, INBRED BALB C; MUCUS; OVALBUMIN; SAPONINS; TH2 CELLS; TRANSFORMING GROWTH FACTOR BETA1; TRITERPENES;

EID: 46749114754     PISSN: 00084212     EISSN: None     Source Type: Journal    
DOI: 10.1139/Y08-053     Document Type: Article

References (36)

1. Aikawa, T., Shimura, S., Sasaki, H., Ebina, M., and Takishima, T. 1992. Marked goblet cell hyperplasia with mucus accumulation in the airways of patients who died of severe acute asthma attack. Chest, 101: 916-921. doi:10.1378/chest.101.4.916. PMID:1555462.
2. Benayoun, L., Druilhe, A., Dombret, M.C., Aubier, M., and Pretolani, M. 2003. Airway structural alterations selectively associated with severe asthma. Am. J. Respir. Crit. Care Med. 167: 1360-1368. doi:10.1164/rccm.200209- 1030OC. PMID:12531777.
3. Bousquet, J., Jeffery, P.K., Busse, W.W., Johnson, M., and Vignola, A.M. 2000. Asthma. From bronchoconstriction to airways inflammation and remodeling. Am. J. Respir. Crit. Care Med. 161: 1720-1745. PMID:10806180.
4. Cho, J.Y., Miller, M., Baek, K.J., Han, J.W., Nayar, J., Lee, S.Y., et al. 2004. Inhibition of airway remodeling in IL-5-deficient mice. J. Clin. Invest. 113: 551-560. doi:10.1172/JCI200419133. PMID:14966564.
5. Cohn, L., Homer, R.J., Marinov, A., Rankin, J., and Bottomly, K. 1997. Induction of airway mucus production by T helper 2 (Th2) cells: a critical role for interleukin 4 in cell recruitment but not mucus production. J. Exp. Med. 186: 1737-1747. doi:10.1084/jem.186.10.1737. PMID:9362533.
6. Elias, J.A., Zhu, Z., Chupp, G., and Homer, R.J. 1999. Airway remodeling in asthma. J. Clin. Invest. 104: 1001-1006. doi:10.1172/JCI8124. PMID:10525034.
7. Gui, S.Y., Wei, W., Wang, H., Wu, L., Sun, W.Y., Chen, W.B., et al. 2006. Effects and mechanisms of crude astragalosides fraction on liver fibrosis in rats. J. Ethnopharmacol. 103: 154-159. doi:10.1016/j.jep.2005.07.025. PMID:16198523.
8. Irwin, R.S., and Richardson, N.D. 2006. Side effects with inhaled corticosteroids: the physician's perception. Chest, 130: S41-S53. doi:10.1378/chest.130.1_suppl.41S.
9. Jeffery, P., and Zhu, J. 2002. Mucin-producing elements and inflammatory cells. Novartis Found. Symp. 48: 51-68. doi:10.1002/0470860790.ch5.
10. Lee, S.H., Choi, S.M., Sohn, Y.S., Kang, K.K., and Yoo, M. 2006. Effect of oryza sativa extract on the progression of airway inflammation and remodeling in an experimental animal model of asthma. Planta Med. 72: 405-410. doi:10.1055/s-2005-916238. PMID:16557453.
11. Leigh, R., Ellis, R., Wattie, J., Southam, D.S., De Hoogh, M., Gauldie, J., et al. 2002. Dysfunction and remodeling of the mouse airway persist after resolution of acute allergen-induced airway inflammation. Am. J. Respir. Cell Mol. Biol. 27: 526-535. doi:10.1165/rcmb.2002-0048OC. PMID:12397011.
12. Locke, N.R., Royce, S.G., Wainewright, J.S., Samuel, C.S., and Tang, M.L. 2007. Comparison of airway remodeling in acute, subacute and chronic models of allergic airways disease. Am. J. Respir. Cell Mol. Biol. 36: 625-632. doi:10.1165/rcmb.2006-0083OC. PMID:17237192.
13. Luo, Y., Qin, Z., Hong, Z., Zhang, X., Ding, D., Fu, J.H., et al. 2004. Astragaloside IV protects against ischemic brain injury in a murine model of transient focal ischemia. Neurosci. Lett. 363: 218-223. doi:10.1016/j.neulet.2004.03.036. PMID:15182947.
14. Makinde, T., Murphy, R.F., and Agrawal, D.K. 2007. The regulatory role of TGF-b in airway remodeling in asthma. Immunol. Cell Biol. 85: 348-356. doi:10.1038/sj.icb.7100044. PMID:17325694.
15. Miller, M., Cho, J.Y., McElwain, K., McElwain, S., Shim, J.Y., Manni, M., et al. 2006. Corticosteroids prevent myofibroblast accumulation and airway remodeling in mice. Am. J. Physiol. Lung Cell. Mol. Physiol. 290: L162-L169. doi:10.1152/ajplung.00252.2005. PMID:16344333.
16. Redington, A.E., Madden, J., Frew, A.J., Djukanovic, R., Roche, W.R., Holgate, S.T., et al. 1997. Transforming growth factor-beta 1 in asthma. Measurement in bronchoalveolar lavage fluid. Am. J. Respir. Crit. Care Med. 156: 642-647. PMID:9279252.
17. Richter, A., Puddicombe, S.M., Lordan, J.L., Bucchieri, F., Wilson, S.J., Djukanovic, R., et al. 2001. The contribution of interleukin (IL)-4 and IL-13 to the epithelial-mesenchymal trophic unit in asthma. Am. J. Respir. Cell Mol. Biol. 25: 385-391. PMID:11588018.
18. Roche, W.R., Beasley, R., Williams, J.H., and Holgate, S.T. 1989. Subepithelial fibrosis in the bronchi of asthmatics. Lancet, 1: 520-524. doi:10.1016/S0140-6736(89)90067-6. PMID:2466184.
19. Rogers, D.F. 2002. Airway goblet cell hyperplasia in asthma: hypersecretory and anti-inflammatory. Clin. Exp. Allergy, 32: 1124-1127. doi:10.1046/j.1365-2745.2002.01474.x. PMID:12190646.
20. Rui, L., Yang, X.Q., Wang, L.J., and Liu, E.M. 2006. Respiratory syncytial virus infection reversed anti-asthma effect of neonatal Bacillus Calmette-Guerin vaccination in BALB/c mice. Pediatr. Res. 59: 210-215. doi:10.1203/01.pdr.0000196368.08210.5c. PMID:16439580.
21. Sears, M.R., Burrows, B., Flannery, E.M., Herbison, G.P., Hewitt, C.J., and Holdaway, M.D. 1991. Relation between airway responsiveness and serum IgE in children with asthma and in apparently normal children. N. Engl. J. Med. 325: 1067-1071. PMID:1891008.
22. Tang, M.L., Wilson, J.W., Stewart, A.G., and Royce, S.G. 2006. Airway remodelling in asthma: current understanding and implications for future therapies. Pharmacol. Ther. 112: 474-488. doi:10.1016/j.pharmthera.2006. 05.001. PMID:16759709.
23. Vignola, A.M., Chanez, P., Chiappara, G., Merendino, A., Pace, E., Rizzo, A., et al. 1997. Transforming growth factor-beta expression in mucosal biopsies in asthma and chronic bronchitis. Am. J. Respir. Crit. Care Med. 156: 591-599. PMID:9279245.
24. Wang, Y.P., Li, X.Y., Song, C.Q., and Hu, Z.B. 2002. Effect of astragaloside IV on T, B lymphocyte proliferation and peritoneal macrophage function in mice. Acta Pharmacol. Sin. 23: 263-266. PMID:11918853.
25. Wills-Karp, M. 2000. Trophic slime, allergic slime. Am. J. Respir. Cell Mol. Biol. 22: 637-639. PMID:10837356.
26. Wills-Karp, M., Luyimbazi, J., Xu, X., Schofield, B., Neben, T.Y., Karp, C.L., et al. 1998. Interleukin-13: central mediator of allergic asthma. Science, 282: 2258-2261. doi:10.1126/science.282.5397.2258. PMID:9856949.
27. Xu, J., Park, P.W., Kheradmand, F., and Corry, D.B. 2005. Endogenous attenuation of allergic lung inflammation by syndecan-1. J. Immunol. 174: 5758-5765. PMID:15843578.
28. Xu, X.L., Ji, H., Gu, S.Y., Shao, Q., Huang, Q.J., and Cheng, Y.P. 2007. Modification of alterations in cardiac function and sarcoplasmic reticulum by astragaloside IV in myocardial injury in vivo. Eur. J. Pharmacol. 568: 203-212. doi:10.1016/j.ejphar.2007.04.007. PMID:17509559.
29. Yao, H.W., Zhu, J.P., Zhao, M.H., and Lu, Y. 2006. Losartan attenuates bleomycin-induced pulmonary fibrosis in rats. Respiration, 73: 236-242. doi:10.1159/000090140. PMID:16330873.
30. Yu, Q.C., Zhu, T.Y., and Zhang, Y.K. 2004. Effect of astragaloside IV on the long-term consequences of renal ischemia-reperfusion injury in rat. Zhonghua Yi Xue Za Zhi. 84: 1412-1415. PMID:15500731.
31. Yu, J., Zhang, Y., Sun, S., Shen, J., Qiu, J., Yin, X., et al. 2006. Inhibitory effects of astragaloside IV on diabetic peripheral neuropathy in rats. Can. J. Physiol. Pharmacol. 84: 579-587. doi:10.1139/Y06-015. PMID:16900242.
32. Zhang, W.J., Hufnagl, P., Binder, B.R., and Wojta, J. 2003. Anti-inflammatory activity of astragaloside IV is mediated by inhibition of NF-kappaB activation and adhesion molecule expression. Thromb. Haemost. 90: 904-914. doi:10.1160/TH03-03-0136. PMID:14597987.
33. Zhang, W.D., Chen, H., Zhang, C., Liu, R.H., Li, H.L., and Chen, H.Z. 2006. Astragaloside IV from Astragalus membranaceus shows cardioprotection during myocardial ischemia in vivo and in vitro. Planta Med. 72: 4-8. doi:10.1055/s-2005-873126. PMID:16450288.
34. Zhang, Z.C., Li, S.J., and Yang, Y.Z. 2007. Effect of astragaloside on myocardial fibrosis in chronic myocarditis. Zhongguo Zhong Xi Yi Jie He Za Zhi. 27: 728-731. PMID:17879539.
35. Zhou, L.F., Zhu, Y., Cui, X.F., Xie, W.P., Hu, A.H., and Yin, K.S. 2006. Arsenic trioxide, a potent inhibitor of NF-κB, abrogates allergen-induced airway hyperrespensiveness and inflammation. Respir. Res. 7: 146. doi:10.1186/1465-9921-7-146. PMID:17178007.
36. + T cells in asthma. Allergy, 63: 509-517. doi:10.1111/j.1398-9995.2007.01580.x. PMID:18070230.